Youll see false positives in EIA screening, but not in LC-MS/MS confirmation
Do not change your semaglutide dosage before talking to your healthcare provider
Given the continued growth of the obesity epidemic, primary care providers should prescribing GLPs for patients with nondiabetic obesity
There has to be an alternative because there is a large group of patients who cant tolerate CPAP. While access, cost and insurance coverage questions remain, the decision adds a new tool to the treatment landscape for Canadians living with obesity and obstructive sleep apnea
Primary outcome measures include assessments of cognition, behavior, ADLs, general health status, A and tau biomarkers in CSF and plasma, MRI, EEG, and oxidative and transmitter biomarkers in the blood
Risk Factors and Safety Considerations for This Population People with untreated or poorly controlled hypothyroidism may experience slower or plateaued weight loss on tirzepatide because their baseline metabolism is suppressed